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Abstract
Background. Microalbuminuria (MA) is a known predic-
tor of cardiovascular disease (CVD) in European origin
populations, but such data are lacking in native Indo-Asian
populations, where CVD risks are high. Major electrocar-
diographic (ECG) changes are predictive of cardiovascular
mortality.WedeterminedtheassociationofMAwithmajor
ECG changes in the general population of Pakistan.
Methods. A total of 3143 subjects aged ≥40 years from
12 randomly selected communities in Karachi participated.
MA was defined as the urine albumin to creatinine (ACR)
ratio of < 300 mg/g creatinine and ≥17 mg/g in men and
≥25mg/ginwomenfromasingle-spotmorningurinesam-
ple. Major changes on ECG were coded in duplicate using
Minnesota classification.
Results. The mean age of subjects was 51.5 (10.7) years.
The median (25–75 percentile) ACR was 4.2 (2.9–7.9)
mg/g in men and 6.0 (3.9–10.8) mg/g in women (P <
0.001). The overall prevalence (95% CI) of MA was 12.3%
(11.1–13.5%), and 20.3% in those with major ECG
changes. In a multivariable model, major ECG changes
(OR,95%CI)(1.50,1.10–2.00),diabetes(3.57,2.93–4.35),
hypertension (2.30, 1.85–2.86), female sex (0.61, 0.53–
0.69), age (1.09, 1.05–1.13, for each 5-year increase) and
eGFR (0.80, 0.78–0.81, for each 10 mg/g increase) were
independently associated with MA.
The presence of MA increased the prevalence of ma-
jor ECG changes from 21 to 31% in those with hyper-
tension (44.9%), 15 to 28% among those with diabetes
(21.4%), 14 to 26% among those with overweight or obe-
sity (68.4%) and 14 to 26% among current users of tobacco
(38.7%) (P < 0.001) each.
Conclusions. The strong association between MA and ma-
jor ECG changes underscores the importance of screen-
ing Indo-Asian subjects for MA for unmasking underlying
CVD, especially those with hypertension, diabetes, obesity,
and tobacco users.
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Introduction
Albuminuria is a known predictor of cardiovascular dis-
ease (CVD) in the Western population [1]. Reduction in
proteinuria may reduce some of this risk [2]. Recent data
suggest that the risk of cardiovascular disease (CVD) due
toproteinuriamaybegraded,continuousandpresentatlev-
els of urine albumin excretion that are even lower than the
current operational definition of microalbuminuria (MA)
[2,3]. The National Kidney Foundation recommends a
gender-specific cut-off of the albumin to creatinine ratio
for screening for MA [4]. Routine screening for MA is rec-
ommendedforallpatientswithdiabetes,butnotnecessarily
in other high-risk groups such as those with hypertension
[5].
Epidemiological studies have shown that major ECG
changesarepredictiveofcardiovascularmorbidityandmor-
tality in men and women.
People of Indo-Asian origin have one of the highest sus-
ceptibilities to coronary artery disease (CAD) in the world
[6,7]. Reports also suggest that compared to European-
origin populations, people of Indo-Asian descent might be
at enhanced risk of MA [8]. However, data on the associ-
ation of MA with CVD in the Indo-Asian population are
scarce and have been inconclusive, in part due to limited
enrolment of Indo-Asian subjects in trials conducted in the
West [9].
The estimation of burden of MA and its strength of
association with CVD along the determinants of this re-
lationship would guide the development of public health
programs for prevention and management of chronic dis-
eases. Such targeted screening strategies could be particu-
larly useful in populations shown to be at high risk of CVD,
diabetes and MA. We therefore conducted these analyses
to determine the prevalence of MA and its association with
major ECG changes in adult representatives of the general
population in Karachi, Pakistan.
Methods
Ethical approval was obtained from Ethics Review Committee at Aga
Khan University, Karachi.
Study design
A cross-sectional study as the first stage of a prospective study of cluster
randomization trial of strategies to control hypertension. Trial registration
number: NCT00327574.
Inclusion criteria
All subjects aged 40 years or above and able to consent.
Exclusion criteria
Poorly mobile patients, those mentally incompetent and unable to give
consent, known advanced liver or kidney failure and pregnancy.
Sampling details
The Federal Bureau of Statistics has divided the city of Karachi into 5000
clusters each of about 250 households. On average, each household con-
tainssevenindividuals,20%ofwhomareaged40yearsorover.About85%
of all clusters (4200) are in the low-income group neighbourhoods (aver-
age household income less than US $120 per month) and were mapped
into 12 geographically contiguous areas of 350 clusters each. One cluster
was randomly selected (computer generated) from each area for inclusion
in the study. A census was done and a listing of all individuals from all
households in the selected areas was made.
Trained community health workers paid home visits to the selected
individuals with an invitation to participate in the study. All subjects were
evaluated after obtaining informed consent. The evaluation included the
following: (a) history and physical examination; (b) questionnaire that
details smoking status, food frequency questionnaire (FFQ) and other
lifestyle factors, known status and World Health Organization (WHO)
Rose questionnaire [10] for angina and international physical activity
questionnaire (IPAQ); (c) assessments of BP with a calibrated automated
device (‘Omron HEM-737TM Blood Pressure Monitor’) in the sitting po-
sition after 5 min of rest; (d) anthropometry (height, weight, waist and
hip circumferences); (e) laboratory tests for risk factors for CVD in-
cluding fasting blood glucose (Synchron Cx-7/Delta, Beckman, USA),
lipid profile (HITACHI-912, Roche Japan), serum creatinine (calibrated
at the Cleveland Clinic Laboratories), spot urine albumin (measured us-
ing nephelometry using the Array Systems method on Beckman Coul-
ter) and urine creatinine (Synchron Cx-7/Delta, Beckman, USA); and
(f) a 12-lead electrocardiogram (ECG). Those with elevated blood pres-
sure, and not on antihypertensive medications, were visited again for re-
measurement of blood pressure on a subsequent visit. All assessments
were performed to a standard protocol that conformed to the interna-
tional standards for definitions and measurements, and external quality
control of albumin measurements were performed by the Bio-Rad Lab-
oratories Inc., Irvine, CA, USA. The study was conducted over 1 year
(2005–06).
Variable definitions
MA was defined as the urine albumin to creatinine (ACR) ratio of < 300
mg/g(34mg/mmol)creatinine,≥17mg/g(1.9mg/mmol)inmenand≥25
mg/g (2.8 mg/mmol) in women, from a single-spot morning urine sample
[11].
Major ECG changes were defined as ECG abnormalities coded in
duplicate according to the Minnesota classification: 4–1 or 4–2 or 5–1 or
5–2 or 6–1 or 6–2 or 7–1 or 7–2 or 8–1 or 8–3 [12,13].
Hypertension was defined as mean systolic BP ≥ 140 mmHg or mean
diastolic BP ≥ 90 mmHg measured 20 min apart, on two separate occa-
sions, or while taking antihypertensive medications.
Diabetes was defined as fasting blood glucose 126 mg/dl (7.0 mmol/l)
or greater or being on antidiabetic medication [14].
Estimated glomerular filtration rate (eGFR) was calculated using the
MDRD study equation [15].
Statistical analysis
AlldataanalysesweredoneinSASversion9.1.2(SASInstituteInc.,Cary,
NC, USA). The prevalence of outcomes (95% CI) was calculated for the
screenedpopulation,accountingfortheclustereddesign.Thedistributions
of variables were compared between the population with and without the
outcome using the t-test for continuous variables and the chi-squared test
for discrete variables.
Multivariable models were built for the primary outcome of MA using
forward stepwise selection with criteria for P = 0.2. Logistic regression
analyses were performed using proc survey logistic in SAS. Candidate
predictors included sociodemographic variables such as age, gender, level
of education, economic status physical activity, smoking status, fasting
blood lipid levels (LDL cholesterol, HDL cholesterol, triglycerides), body
mass index, waist circumference, major ECG changes, hypertension and
diabetes. Factors associated with MA with P < 0.05 were retained in the
final model. We also searched for interactions between factors associated
with MA and major ECG changes on MA.
Results
A target sample population of 3546 subjects aged 40 years
or over, stratified by sex were invited to enrol in the study.
A total of 3143 (88.6%) of the invited subjects consented to
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mean age of the subjects was 51.5 (10.7) years and 48%
were males. The characteristics of the subjects are shown
in Table 1.
The median urine albumin to creatinine ratio (25–75th
percentile) was 5.2 (3.3–9.5) mg/g: 4.2 (2.9–7.9) mg/g in
men and 6.0 (3.9–10.8) mg/g in women (P < 0.001)). The
overall prevalence of MA was 12.3%: 13.5% in men and
11.1% in women (P = 0.05).
The unadjusted and adjusted odds for factors associated
with MA are shown in Table 1. Increase in age, decrease
in estimated GFR, and presence of diabetes, hypertension
and major changes on ECG each were independently and
positively associated with MA. None of the interactions
were statistically significant.
Figure 1 illustrates the increase in the prevalence of
major ECG changes in the presence of MA in the over-
all study population, as well as in subgroups with hyper-
tension, diabetes, overweight or obesity and with tobacco
use.
Discussion
The Indo-Asian population accounts for one-sixth of the
world’sinhabitants.Thisisthefirstreportontheprevalence
of MA and its relationship with CVD from a representative
general population of an urban Indo-Asian city. We found
that MA was independently associated with major ECG
changes in men and women. Subjects with hypertension,
diabetes, overweight or obesity and tobacco users exhibited
a significant increase in the prevalence of ECG abnormali-
ties in the presence of MA. These findings underscore the
importance of screening Indo-Asians for MA, especially
the individuals at high risk of CVD.
ReportsinmigrantIndo-AsianpopulationswithMAsug-
gest a faster progression of kidney disease compared to
native Europeans [16]. However, data on prevalence, de-
terminants and clinical conditions associated with MA in
the native Indo-Asian populations are somewhat limited.
These populations are relatively unique in terms of experi-
encing a double burden of undernutrition as well as rising
rates of overweight and obesity, both enhancing suscepti-
bility to chronic diseases including hypertension, diabetes,
cardiovascular and kidney diseases [17].
Prevalence of MA
We found a high prevalence of MA in the order of 12.3%
in the overall population aged 40 years or above. This
burden was substantially greater among those with hyper-
tension (18.9%) and diabetes (26.6%). While comparable
population-based representative data on MA are not avail-
able from the Asia–Pacific region, the Microalbuminuria
Prevalence Study (MAPS) reported a prevalence of 39.8%
in a total of 6800 hypertensive diabetic adult patients from
10 Asian countries [18]. These findings and others from
the region are consistent with those observed in the sub-
jects with diabetes in our study [19,20].
Factors associated with MA
We found that the conventional predictors of MA (which
also predict CVD) such as hypertension, diabetes and
low eGFR were also independently associated with MA
(Table 1). However, the association of MA with major
ECG changes persisted even after accounting for these
risk factors, indicative of incremental contribution of MA
per se or its role as a marker of end organ damage. Con-
sistent with this, the presence of MA was significantly
associated with the concomitant presence of major ECG
changes by 1.5-fold in those with hypertension and by 2-
fold in those with diabetes, obesity or in tobacco users
(Figure 1).
Implications of findings
Althoughtheprecisemechanismoftheassociationbetween
MA and CVD remains unknown, a common underlying en-
dothelial pathology seems a plausible common link. It is
critical to underscore that this association was present in
thosewithandwithoutotherriskfactorsforCVD(diabetes,
hypertension, obesity). If confirmed, this relationship may
call for the modification of the approach to evaluation and
management of several high-risk conditions. For instance,
theexistingJNC-7guidelinesforcardiovascularriskassess-
mentinnon-diabeticsubjectswithhypertensionincludethe
assessment of dipstick proteinuria or clinical albuminuria
only [5] and the measurement of MA is recommended only
among those with diabetes. Our findings would suggest
that all hypertensive subjects should be screened for MA
regardless of diabetes status, as its presence would indi-
cate existing end organ damage. The same would apply to
obese subjects and smokers. In fact, post hoc analysis of
data from Losartan Intervention For Endpoint Reduction
(LIFE) in the hypertension study suggests a potential role
of MA as a modifiable risk factor on CVD as benefit of
lowering albuminuria with Losartan on left ventricular hy-
pertrophy [21]. Randomized controlled trials are needed
to determine whether more aggressive management such
as intensive control of blood pressure or lipids or use of
blockers of RAAS is warranted for prevention of CVD in
subjects with MA.
Limitations
Our study has limitations; first, we tested only a single
urine sample, while confirmed diagnosis of MA requires
persistence on at least two out of three consecutive tests.
Moreover, concomitant haematuria and pyuria were not
ruled out as their presence may indicate transient albumin-
uria. However, a single urine test is considered appropriate
for epidemiological studies [22]. Second, ECG findings
have not been validated in the Indo-Asian population.
However, MA has been associated with CVD mortality
in other populations, and our findings of the link between
MA and major ECG changes suggest that the same is
likely to apply to Indo-Asians as well [23]. Third, MDRD
Study equations may be suboptimal for use in Indo-Asians,
requiring a correction factor or new equation for precise2114 T. H. Jafar et al.
Table 1. Baseline population characteristics
Individuals with MA Unadjusted odds Adjusted odds ratio Adjusted odds ratio
Variables Total (2891) (n = 355) ratio model I model II
Age (years), mean (SD) 51.5 (10.7) 56.3 (11.7) 1.23 (1.21–1.26)
(each 5 year
increase)
1.22 (1.20–1.25)
(each 5 year
increase)
1.09 (1.05–1.13)
(each 5 year
increase)
Gender, n (%)
Men 1379 (47.7) 187 (13.5) 1 1 1
Women 1513 (52.3) 168 (11.1) 0.80 (0.67–0.96) 0.78 (0.65–0.93) 0.61 (0.53–0.69)
Educational attainmenta, n (%)
Illiterate 1000 (34.6) 137 (13.7) 1.22 (0.95–1.57) NS NS
Literate 1892 (65.4) 218 (11.5) 1
SESb n (%)
Low 2002 (69.2) 234 (11.7) 1 NS NS
Middle 890 (30.8) 121 (13.6) 1.19 (0.83–1.70)
Current tobacco userc, n (%)
No 1771 (61.3) 213 (12.0) 1 NS NS
Yes 1119 (38.7) 142 (12.7) 1.06 (0.85–1.33)
Physical activity METd
(min/week)
<840 1769 (61.2) 244 (13.8) 1.45 (1.14–1.85) 1.35 (1.05–1.74) NS
≥840 1123 (38.8) 111 (9.9) 1 1
Waist circumference
(cm) (SD)
89.6 (12.4) 92.0 (12.4) 1.19 (1.13–1.25) – NS
Central obesitye, n (%) 1936 (66.9) 256 (13.2) 1.32 (1.03–1.69) – NS
Body mass index, mean (SD) 25.7 (5.7) 25.8 (5.3) 1.00 (0.98–1.03) – NS
Overweight/obesityf, n (%) 1976 (68.4) 244 (12.4) 1.04 (0.80–1.36) – NS
Serum cholesterol
(mg/dl), mean (SD)
187.9 (39.3) 193.2 (47.5) 1.00 (1.00–1.01) – NS
HDL, mean (SD) 40.2 (10.2) mg/dl
1.03 (0.26) mmol/l
39.7 (10.3) 1.02
(0.26).mmol/l
0.94 (0.90–0.99),
each 10 mg/dl
increase
–N S
LDL, mean (SD) 115.5 (30.8) mg/dl
2.96 (0.79).mmol/l
118.0 (36.7) mg/dl
3.03 (0.94).mmol/l
1.03 (1.01–1.05)
each 10 mg/dl
increase
–N S
Triglycerides, mean (SD) 159.3 (95.5) mg/dl
1.79 (1.07) mmol/l
184.0 (111.8) mg/dl
2.07 (1.26) mmol/l
1.02 (1.01–1.04)
(each 10 mg/dl
increase)
– 1.01 (1.01–1.02)
(each 10 mg/dl
increase)
Hyperlipidaemiag, n (%) 1007 (34.9) 136 (13.5) 1.20 (0.93–1.54) – NS
Diabetesh, n (%) 616 (21.4) 164 (26.6) 3.97 (3.40–4.64) – 3.57 (2.93–4.35)
Hypertensivesi, n (%) 1279 (45.0) 241 (18.9) 3.22 (2.60–3.97) – 2.30 (1.85–2.86)
CADj, n (%) 150 (5.2) 27 (18.2) 1.64 (0.94–2.86) – NS
Positive Rose angina
questionnaire, n (%)
372 (12.9) 40 (10.8) 0.85 (0.58–1.25) – NS
Major ECG
abnormalitiesk, n (%)
462 (16.0) 94 (20.3) 2.11 (1.56–2.87) – 1.50 (1.10–2.00)
Composite CHD (CHD
+ Rose)l, n (%)
956 (33.1) 145 (15.2) 1.47 (1.16–1.86) – NS
Q Waves changesm, n (%) 65 (2.2) 11 (16.9) 1.47 (0.86–2.51) – NS
eGFRn (ml/min/
1.73 m2) mean (SD)
85.1 (20.0) 75.0 (23.8) 0.73 (0.72–0.75)
(each 10 ml/min/
1.73 m2 increase)
– 0.80 (0.78–0.81)
(each 10 ml/min/
1.73 m2 increase)
aEducational attainment: illiterate: no formal education and cannot read or write at all; literate: can read and write with understanding or completeda t
least V grade of formal education.
bSES was extracted from Pakistan Social and Living Standards Measurement Survey (PSLM) 2006–07 Federal Bureau of Statistics.
cCurrent tobacco users were defined as having tobacco in the form of smoking or chewing for at least 100 times in their lifetime or currently using.
dPhysical activity MET (Metabolic Equivalent) Score was defined as follows:
Total MET-minutes/week = Walk (METs − min∗days) + Moderate (METs∗min∗days) + Vigorous (METs∗min∗days).
eCentral obesity was defined as having a waist circumference of ≥80 cm in women and ≥90 cm in men.
fOverweight/obesity was defined as Asian specific criterion of ≥23 kg/m2.
gHyperlipidaemia was defined as fasting serum cholesterol of ≥5.18 mmol/l (≥200 mg/dl).
hDiabetes was defined as patients taking antidiabetic drugs or fasting glucose level ≥126 mg/dl.
iHypertension defined as patients taking antihypertensive drugs or mean systolic blood pressure ≥140 mmHg or mean diastolic blood pressure ≥90
mmHg.
jCAD defined as presence of major Q-waves on ECG or history of heart attack diagnosed by a doctor.
kMajor ECG abnormalities defined as the following codes on ECG: Minnesota codes 4–1 or 4–2 or 5–1 or 5–2 or 6–1 or 6–2 or 7–1 or 7–2 or 8–1 or
8–3.
lComposite CHD: coronary artery disease was defined as the outcome of ischaemia on ECG (Minnesota codes 1–3 or 4–1 or 4–2 or 4–3 or 5–1 or 5–2
or 5–3 or 7–1) or past history of heart attack or Q-waves changes (Minnesota codes 1–1 to 1–2) or Positive Rose angina questionnaire.
mQ-wave changes: Minnesota codes 1–1 to 1–2.
neGFR: GFR is estimated for.
Male: [186 × ((sc)−1.154] × [(age in years)−0.203)].
Female: [(186 × ((sc)−1.154] [(age in years)−0.203)) × 0.742].
LDL or HDL: to convert mg/dl to mmol/l, divide by 39.
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Fig. 1. Association of major ECG changes and microalbuminuria (MA).
estimation [24,25]. However, our use of estimated GFR as
a continuous term in the multivariable model is likely to
account for the relationship between unit changes in level
kidney function in albuminuria independent of major ECG
changes.
Finally, ours was a cross-sectional study, and the direc-
tion of causality cannot be established. Nevertheless, we
demonstrate a strong association between MA and major
abnormalities on ECG.
Strengths and conclusion
The major strengths of our study include a large repre-
sentative sample from the general population and use of a
validated screening tool for assessing MA [26].
In conclusion, ours is the first study on the prevalence
of MA based on a representative adult population of an ur-
ban city in Indo-Asia, and the first to show the association
between MA and major abnormalities on ECG in this pop-
ulation. We found a high burden of MA in the native urban
Indo-Asian population, and an independent association of
MA with major ECG changes. These findings highlight the
potential role of MA as a risk factor or a marker of CVD in
this population. Thus, screening for MA may help identify
and risk stratify Indo-Asians in need of intensive cardio-
vascular risk management. These findings have substantial
implicationsfornativeandmigrantIndo-Asianpopulations
globally. Future studies are needed to elucidate whether
aggressive management for CVD risk reduction including
lowering albumin excretion levels in Indo-Asian subjects
with MA confers an advantage from CVD morbidity and
mortality [27].
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